Skip to content

Comparative Study between Mesotherapy and Topical 2% Minoxidil for Female Androgenic Alopecia

Comparative Study between Mesotherapy and Topical 2% Minoxidil for Female Androgenic Alopecia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110837
Enrollment
Unknown
Registered
2025-10-21
Start date
2022-10-16
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Androgenetic Alopecia

Interventions

Experimental group:Mesoderm therapy
Control group:Topical Minoxidil

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy women aged 18-60; 2. All patients meet the diagnostic criteria for androgenetic alopecia in the "Chinese Guidelines for the Diagnosis and Treatment of Androgenetic Alopecia"; 3. Blood and urine tests, liver and kidney function, and autoantibody profiles are all within normal ranges, excluding hair loss caused by other reasons; 4. Patients are informed about this study and agree to participate; 5. The degree of hair loss corresponds to Ludwig scale I-II in women.

Exclusion criteria

Exclusion criteria: 1. Physical examination or laboratory tests show significant abnormalities; 2. Have undergone surgery to correct hair loss; 3. Have used other methods to treat hair loss within one year, such as oral anti-androgen drugs, finasteride, or other 5a-reductase inhibitors, as well as hair loss caused by other reasons.

Design outcomes

Primary

MeasureTime frame
Hair density;Hair Diameter;

Countries

China

Contacts

Public ContactWang Xiaodan

Beijing You'an Hospital, Capital Medical University

bzmcwangxd@163.com+86 188 1025 2752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026